clinical trial · NCT00300755
Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)
Wyeth is now a wholly owned subsidiary of Pfizer·phase3·completed·n = 60
Gastroesophageal Refluxpantoprazole sodium enteric-coated spheroid
brief summary
To evaluate the clinical outcomes of treatment with oral pantoprazole in children 1 through 5 years of age with endoscopically proven symptomatic GERD.
started
May 1, 2006
primary completion
Apr 1, 2008
completion
Apr 1, 2008
last updated
Sep 25, 2026
official title
A Multicenter, Randomized, Double-Blind Study of the Clinical Outcomes, Safety and Tolerability of Multiple Doses of Pantoprazole Sodium Enteric-Coated Spheroids in Children Ages 1 to 5 With Endoscopically Proven Symptomatic Gastroesophageal Reflux Disease (GERD)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol